To whomever it concerns,
Throughout my career, I’ve worked at the intersection of engineering, biotechnology, and healthcare. I used these opportunities to hone my skills in conceptualizing software products based on scientists’ requirements, designing and building software applications, and delivering a tangible impact to scientists and physicians in academia and industry alike.
In my role as the sole engineer at Denali Therapeutics, I built software solutions alongside different -omics groups from initial whiteboarding to full production to aid in Alzheimer’s therapeutics. At Octant, I led multiple software projects from automated experiment design to machine learning analysis pipelines. These multifaceted roles were a combination of my skills in both software development and scientific collaboration in order to provide seamless solutions that would directly impact bottom lines of our internal teams such as screening and high-throughput chemistry.
The world is experiencing a revolution in computing. Hardware improvements in chip design and manufacturing have resulted in exponential growth in our ability to ingest, transform, predict, and increasingly consume data. The sheer quantity and scale of scientific data is no longer a bottleneck, but a feature that we can use to power new algorithms to give us insight into biological pathways and systems.
These generated insights will be the rationale behind future life-saving drugs and medicines. However, to fully utilize these breakthroughs, we must have both high-quality data that is standardized and contextualized, as well as a quantity of data large enough for these systems to learn.
The barriers to compound procurement and management can be divided into three main challenges:
A better system needs to be in place to factor in logistical and industrial realities as chemists must navigate the intricacies of sourcing vendors, negotiating prices, and figuring out packaging and shipping times. Many of these processes are still manually managed through email, Excel, or overpriced or outdated software.
In order to address these barriers, my initial solution focuses on building a software platform that horizontally captures users through the procurement and management pipeline.
The key features include:
To achieve these goals, I would greatly benefit from working with those who have a strong background in chemistry or direct experience in high-throughput chemistry within industry. Additionally, I am eager to learn from others who have experience in scaling a business and interacting with investors and financial models.
I’m looking forward to working with future collaborators of diverse backgrounds.